By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
.
The examination that assesses the electrical activity of the heart is called a resting electrocardiogram. The sinus node, the heart’s natural pacemaker, produces electric impulses that cause the muscular heart to contract rhythmically to pump blood.
No movement is permitted throughout the test because the electrical impulses produced by different muscles may conflict with the heart’s electrical impulses. The average time for this kind of ECG is 5 to 10 minutes.
The Global Resting ECG market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
A new electrocardiography system from GE Healthcare, the MAC3500, was introduced to measure resting ECG analysis. The MAC 3500 system, which is ideal for basic 12-lead resting ECG analysis, provides technologies to aid doctors in enhancing the reliability and accuracy of cardiac assessments while also aiding in increasing productivity and efficiency.
Our lineup of electrocardiographs has been greatly enhanced by the MAC 3500. The ECG is still a crucial diagnostic tool for cardiovascular illness since it can detect the existence and extent of heart disease without using any invasive procedures.
The ECG offers providers in pre-hospital and hospital settings an effective and affordable solution. They are optimistic that their new GE electrocardiograph will support physicians in their practice and that clinicians will be happy with its overall design, functionality, and utility.
A new era of patient care is being shaped by the revolutionary medical technologies and services offered by GE Healthcare. They are assisting clinicians all over the world to re-imagine new ways to predict, diagnose, inform, and treat disease so that their patients can live their lives to the fullest.
Their expertise spans medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies.
Healthcare professionals may better identify and treat cancer, heart disease, neurological illnesses, and other conditions earlier thanks to the wide range of devices and services offered by GE Healthcare. Their goal is to make it possible for a new “early health” style of care that focuses on earlier disease detection and pre-symptomatic diagnosis.
